Rohan Xu, MD

@marklewismd Sounds reasonable🤣🤣🤣

@Rohan13082924 Moral support?

What it feels like when someone says “pull yourself up by your bootstraps”

@Dr_AmerZeidan Location: Guangzhou China. Every outpatient day we can receive 2-3 newly diagnosed MDS/MPN pts. Targeted seq/WES and cytogenetics are commonly performed unless financially unaffordable. HMA, ESA, LEN, cyclosporine are most frequently used. BMT is recommanded in pts<65.

@Dr_AmerZeidan Hans Landa! Can't agree more! And his talent for mastering so many languages!👍👍👍

One of the most talented (& under appreciated despite the Oscars) actors who we should have seen many more movies from!

@oostendorp_lab Rigorous and inspiring work! Congratulations!😄😄😄 We are now working on the FPR deficiencies of patient-derived MSCs from leukemia. Hoping to share our findings with you and your excellent team in future.🤩

Now in print: ... Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300 ... wonderful work by a super talented team doi.org/10.3324/haemat…

@guangchuangyu 内蒙古的羊肉绝啦！😄

已经毕业的学生从内蒙古给我寄了羊腿和羊排，学生的投喂让我感动。不敢发朋友圈，免得其他学生看到跟风给我寄东西，但还是想记录一下，于是发个推。#第一届毕业生都很不错

The countdown is on! Only 12 more days until #ASH22 🤓 Which colleagues are you most excited to see? Tag them in your reply 👇 & plan what sessions you'll be attending together 🧑‍🤝‍🧑: loom.ly/4N-GJhs

@theworldofdog and he made it obiviously😆

@slava__bobrov oh he tried so hard🙏

Brain cell looking for connection: Credit: ASTARmicroscopy

@rmassonix guese it's just a results from a 'letter to editor' or a 'correspondence' with limitation on the number of figures

17 panels in a single figure, that's a new record

@drsangeetmd @DavidSteensma Sounds interesting😉Downloading

History is always humbling & fascinating!!! I did not know that platelets were called “blood dust”- Now I do!! Utterly enjoyable read written by one of my favorite scientific authors @DavidSteensma. #leusm #MedTwitter #mdssm

且听龙吟

My personal view on phase 3 studies in MDS: Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendations - PubMed ⁦@MDAndersonNews⁩ out in Lancet Hematology ⁦@TheLancetHaem⁩ pubmed.ncbi.nlm.nih.gov/36215988/

Multicenter study adding venetoclax to aza in hma failure mds. Similar results to our recent paper in lancet hematology. Dont see clear path forward unless we understand subsets that benefit. ⁦@MDAndersonNews⁩ pubmed.ncbi.nlm.nih.gov/36309981/

Assistant professor vs Editor

Excellent discussion in @TheIACH journal club with @garciamanero and @thomas_cluzeau moderated by @Mohty_EBMT on recent @TheLancetHaem phase 1 study of aza-ven in #MDSsm

Com on, little ones! Just try your best to give me a beautiful CFU-GEMM🧐🙏🤣💪💪💪 Putting all my hairline for this bet😆

@HoodLeakTV Taser or real?

Why did she think this was OK to do?💀🤮

This is a macrophage REPAIRING A BROKEN BLOOD VESSEL #MedTwitter #biology

Grandma?!